Download Files:
ZLD115
SKU
HY-149334-Get quote
Category Reference compound
Tags Fat Mass and Obesity-associated Protein (FTO), Metabolic Disease, Metabolic Enzyme/Protease
Products Details
Product Description
– ZLD115 (compound 44) is a FB23-derivated inhibitor of Fat Mass and Obesity-associated Protein (FTO). ZLD115 is an antileukemic agent, exhibiting antiproliferative activity against leukemic cell lines[1].
Web ID
– HY-149334
Shipping
– Room temperature
Molecular Formula
– C27H30ClN3O4
References
– [1]Xiao P, et al. Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties. J Med Chem. 2023 Jul 7.
Molecular Weight
– 496.00
SMILES
– O=C(C1=C(C=CC=C1NC2=C(C=C(C=C2C3CC3)C4=C(ON=C4C)C)Cl)CN5CCCOCC5)O
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– 10 mM in DMSO
Target
– Fat Mass and Obesity-associated Protein (FTO)
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.